Carnegie Investment Counsel’s Humana HUM Stock Holding History

Carnegie Investment Counsel’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-769	Closed	-$244K	–	471
2024 Q3	$244K	Hold	769	–	–	0.01%	426
2024 Q2	$287K	Hold	769	–	–	0.01%	409
2024 Q1	$267K	Sell	769 -180	-19%	-$68.2K	0.01%	434
2023 Q4	$434K	Hold	949	–	–	0.01%	366
2023 Q3	$462K	Sell	949 -46	-5%	-$21.6K	0.02%	358
2023 Q2	$445K	Sell	995 -1	-0.1%	-$503	0.02%	368
2023 Q1	$484K	Buy	996 +52	+6%	+$25.7K	0.02%	362
2022 Q4	$484K	Buy	944 +2	+0.2%	+$1.05K	0.02%	359
2022 Q3	$457K	Buy	942 +15	+2%	+$7.3K	0.02%	346
2022 Q2	$434K	Buy	927 +9	+1%	+$4K	0.02%	354
2022 Q1	$399K	Buy	918 +50	+6%	+$20.9K	0.01%	376
2021 Q4	$403K	Buy	868 +99	+13%	+$43.8K	0.01%	381
2021 Q3	$299K	Hold	769	–	–	0.01%	388
2021 Q2	$340K	Buy	+769	New	+$336K	0.01%	376

Other funds holding HUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Eagle Capital Management (New York) New York $32.7B AUM 17.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Carnegie Investment Counsel's HUM Position: Q4 2024 in Review

Carnegie Investment Counsel sold out of Humana (HUM) in Q4 2024, closing a stake of 769 shares — an estimated $244K sold.

Carnegie Investment Counsel first reported a position in HUM in Q2 2021 and held it in 14 quarters. The position peaked at $484K in Q1 2023. 880 funds tracked by Wall St. Rank hold HUM as of Q4 2024.

Carnegie Investment Counsel reported no remaining Humana position as of Q4 2024 after selling out during the quarter.
Carnegie Investment Counsel sold 769 Humana shares in Q4 2024, an estimated $244K.
Carnegie Investment Counsel first reported a position in Humana in Q2 2021 and held it in 14 quarters.
Carnegie Investment Counsel's Humana position peaked at $484K in Q1 2023.
880 funds tracked by Wall St. Rank held Humana as of Q4 2024.

Based on Carnegie Investment Counsel's 13F filing for Q4 2024, filed 15 Jan 2025.